Despite the success of its new weight loss drug Zepbound, Lilly's recent earnings failed to meet expectations.

Analyst David Risinger of Leerink Partners reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), retaining the price target of ...

What role did partnerships with area organizations play in securing Indiana Tech’s $21.5 million Lilly Endowment grant?

Ricks is being recognized for his contributions to Indiana’s life sciences sector and his global impact on health care ...

Barclays analyst Carter Gould maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today and set a price target of $975.00.

BioCrossroads has named Eli Lilly CEO, Dave Ricks, the recipient of the 2024 August M. Watanabe Life Sciences Champion of the ...

Hoosiers’ out-of-pocket health care spending is higher than in neighboring states, and a new Indiana University analysis ...

While sophomore guard Juliana LaMendola scored just 1 point for Indiana, Moren complimented her defensive efforts against a ...

Indiana made it a one-possession game going into halftime by closing out the second quarter with an 11-0 run. The Hoosiers ...

New data from an Indiana University analysis suggests that aggregate health care spending in the state is on par with other ...

Indiana women's basketball team bounces back with impressive win over Stanford, observations from the key non-conference ...